JP2007509984A5 - - Google Patents

Download PDF

Info

Publication number
JP2007509984A5
JP2007509984A5 JP2006538385A JP2006538385A JP2007509984A5 JP 2007509984 A5 JP2007509984 A5 JP 2007509984A5 JP 2006538385 A JP2006538385 A JP 2006538385A JP 2006538385 A JP2006538385 A JP 2006538385A JP 2007509984 A5 JP2007509984 A5 JP 2007509984A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pedf
composition according
peptide
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006538385A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007509984A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/036245 external-priority patent/WO2005041887A2/en
Publication of JP2007509984A publication Critical patent/JP2007509984A/ja
Publication of JP2007509984A5 publication Critical patent/JP2007509984A5/ja
Pending legal-status Critical Current

Links

JP2006538385A 2003-10-29 2004-10-29 色素上皮由来因子、その新規な生物活性及びその使用方法 Pending JP2007509984A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51537403P 2003-10-29 2003-10-29
PCT/US2004/036245 WO2005041887A2 (en) 2003-10-29 2004-10-29 Pigment epithelium-derived factor, novel biological activity and methods of use

Publications (2)

Publication Number Publication Date
JP2007509984A JP2007509984A (ja) 2007-04-19
JP2007509984A5 true JP2007509984A5 (enExample) 2007-12-13

Family

ID=34549400

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006538385A Pending JP2007509984A (ja) 2003-10-29 2004-10-29 色素上皮由来因子、その新規な生物活性及びその使用方法

Country Status (6)

Country Link
US (1) US20080293626A1 (enExample)
EP (1) EP1684692A2 (enExample)
JP (1) JP2007509984A (enExample)
CN (1) CN101014358A (enExample)
AU (1) AU2004285562B2 (enExample)
WO (1) WO2005041887A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173591B2 (en) 2004-11-16 2012-05-08 Yeda Research And Development Co. Variants of pigment epithelium derived factor and uses thereof
WO2006091459A2 (en) * 2005-02-24 2006-08-31 Joslin Diabetes Center, Inc. Compositions and methods for treating vascular permeability
EP1951284A4 (en) 2005-11-14 2010-05-05 Yeda Res & Dev IMPROVED VARIANTS OF DERIVED FACTOR OF PIGMENTARY EPITHELIUM AND USES THEREOF
EP1986676A4 (en) * 2006-02-15 2009-11-04 Univ Yale Inc COMPOSITIONS AND METHODS FOR USE OF PEDF (PIGMENT-BASED EPITHELIC DERIVED FACTOR) PEPTIDE FRAGMENTS
ES2329636B2 (es) * 2006-02-17 2010-07-26 Universitat De Valencia, Estudi General (Participa Con El 70%) Uso del factor pedf para inducir la auto-renovacion de celulas madre.
WO2008091692A2 (en) * 2007-01-25 2008-07-31 Joslin Diabetes Center, Inc. Methods of diagnosing, treating, and preventing increased vascular permeability
AU2009227206A1 (en) * 2008-03-18 2009-09-24 Kurume University Polypeptide and pharmaceutical composition containing the polypeptide
EP2486128A4 (en) * 2009-10-08 2013-10-09 Neurotech Usa Inc USE OF THE PEDF IN AN ENCAPSULATED CELL DELIVERY SYSTEM
EP2508196B1 (en) 2011-03-23 2018-09-26 Mackay Memorial Hospital Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing
US20130046283A1 (en) * 2011-05-05 2013-02-21 Medtronic Vascular, Inc. Methods and intravascular treatment devices for treatment of atherosclerosis
TWI554521B (zh) * 2011-10-19 2016-10-21 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 色素上皮衍生因子衍生之多胜肽於治療禿髮和／或毛髮脫色之用途
CN102757497B (zh) * 2012-07-16 2014-09-17 中山大学 一种抗pedf单克隆抗体及其制备方法和应用
US9938328B2 (en) 2012-09-17 2018-04-10 Mackay Memorial Hospital Use of PEDF-derived polypeptides for treating alopecia and/or hair depigmentation
KR101830926B1 (ko) 2012-09-19 2018-02-22 맥케이 메모리얼 호스피탈 피부 노화를 방지 및/또는 개선하기 위해 사용되는 pedf-유도 폴리펩티드의 용도
TWI449532B (zh) * 2012-09-19 2014-08-21 Mackay Memorial Hospital 色素上皮衍生因子衍生之多胜肽於預防和／或緩和皮膚老化之用途
EP2897974B1 (en) * 2012-09-20 2018-03-28 Mackay Memorial Hospital Use of pedf-derived polypeptides for treating osteoarthritis
TWI491407B (zh) * 2012-09-20 2015-07-11 Mackay Memorial Hospital 色素上皮衍生因子衍生之多胜肽於治療骨性關節炎之用途
WO2015038891A2 (en) 2013-09-13 2015-03-19 The Penn State Research Foundation Functional peptide analogs of pedf
EP3122884B1 (en) * 2014-03-26 2019-12-25 Tocagen Inc. A retroviral vector having immune-stimulating activity
RU2708375C2 (ru) * 2015-03-02 2019-12-06 Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Иллинойс Пептиды для ингибирования ангиогенеза
KR20230169375A (ko) * 2016-10-07 2023-12-15 브림 바이오테크놀로지, 인코퍼레이티드 Pedf-유래 짧은 펩타이드를 포함하는 조성물 및 그것의 사용
JP6469767B2 (ja) * 2017-07-05 2019-02-13 マクカイ メモリアル ホスピタル 皮膚老化を予防及び／又は改善するためのｐｅｄｆ−由来ポリペプチドの使用
JP6522063B2 (ja) * 2017-08-10 2019-05-29 マクカイ メモリアル ホスピタル 脱毛症及び／又は毛髪色素脱失を治療するためのｐｅｄｆ由来のポリペプチドの使用
EA202092366A1 (ru) * 2018-04-08 2021-01-26 Брим Байотекнолоджи, Инк. Применение происходящих из pedf коротких пептидов при лечении остеоартрита
CN111760019B (zh) * 2019-08-16 2023-09-05 董红燕 Pedf在制备保护慢性肺损伤药物中的应用
CN112390877B (zh) * 2019-08-16 2022-10-04 董红燕 Pedf衍生多肽组合物及其在制备保护肺损伤药物中的应用
KR102798478B1 (ko) * 2019-08-27 2025-04-18 요우 핑 차오 짧은 합성 펩티드 및 망막 변성 질환 및/또는 조직 손상 치료를 위한 용도
KR20230106115A (ko) * 2019-10-06 2023-07-12 브림 바이오테크놀로지, 인코퍼레이티드 Pedf-유래된 짧은 펩타이드 (pdsp)를 포함하는 조성물 및 그것의 사용
CN114057831B (zh) * 2020-08-07 2024-03-12 三凡生技研发股份有限公司 促进血管增生的短链胜肽及其促进糖尿病伤口愈合的用途
AU2024388722A1 (en) * 2023-11-29 2026-06-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modified pigment epithelium-derived factor peptides and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010021382A1 (en) * 1991-03-29 2001-09-13 Genentech, Inc. Vascular endothelial cell growth factor antagonists
US6451763B1 (en) * 1992-06-04 2002-09-17 The United States Of America As Represented By The Department Of Health And Human Services Retinal pigmented epithelium derived neurotrophic factor and methods of use
US7105496B2 (en) * 1998-07-23 2006-09-12 Northwestern University Methods and compositions for inhibiting angiogenesis
US6821775B1 (en) * 2000-02-11 2004-11-23 Genvec, Inc. Viral vector encoding pigment epithelium-derived factor
EP1265627B1 (en) * 2000-02-23 2008-11-05 Northwestern University Pharmaceutical compositions for inhibiting angiogenesis by pedf fragments
US20020164668A1 (en) * 2000-04-03 2002-11-07 Durham L. Kathryn Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
IL147444A0 (en) * 2002-01-03 2002-08-14 Yeda Res & Dev Process for the production of pigment epithelium derived factor (pedf) from human blood and uses thereof
US20030158112A1 (en) * 2002-02-15 2003-08-21 Johns Hopkins University School Of Medicine Selective induction of apoptosis to treat ocular disease
US20060189519A1 (en) * 2002-09-26 2006-08-24 Karl Volz Anti-angiogenic fragments fo pigment epithelium-derived factor (pedf)
JP2006516027A (ja) * 2002-12-02 2006-06-15 ジェンベク、インコーポレイティッド 眼関連障害の治療用材料および治療方法
CA2559436A1 (en) * 2004-03-12 2005-09-29 Genvec, Inc. Materials for treating vascular leakage in the eye

Similar Documents

Publication Publication Date Title
JP2014526441A5 (enExample)
JP2011526886A5 (enExample)
CN103476933B (zh) 白介素1受体的拮抗剂
JP2013506411A5 (enExample)
JP2016519134A (ja) 腎薬物標的化のためのペプチドおよびペプチド−活性成分の接合体
JP2015504666A5 (enExample)
JP2012115277A5 (enExample)
JP2011526303A5 (enExample)
JP2022500078A5 (enExample)
JP7834637B2 (ja) 治療用融合タンパク質
DK2994152T3 (en) CONJUGATES FOR PROTECTION AGAINST NEPHROTOXIC ACTIVE SUBSTANCES
JP2014050390A5 (enExample)
JP2019533722A5 (enExample)
US20210363224A1 (en) IL13Ra2 PEPTIDE AND ITS USES
JP2010524968A5 (enExample)
JP2009535330A5 (enExample)
JP2009502803A5 (enExample)
JP2017524727A5 (enExample)
WO2009156473A1 (en) Derivatised hybrid peptides of amylin and salmon calcitonin
JP2022526367A (ja) リポカリンムテインの吸入投与
CN107949372A (zh) 烯醇酶1（Eno1）组合物及其用途
JP2025116068A (ja) 腎臓活性融合タンパク質及びそれを使用する治療方法
JP2008531463A5 (enExample)
JP2017500849A5 (enExample)
EP4192843A1 (en) Peptides able to bind angiotensin-converting enzyme 2 (ace2) and medical uses thereof